For anyone interested in keeping up with my personal growth and development, and projects I'm working on, follow my monthly newsletter at this link for a brief monthly update on everything I do! Check it out: https://t.co/gIO1wqEuJR
"The existence of two acute myeloid leukaemia classification systems...is concerning... and threatens the ability to... deliver appropriate... management strategies"
NEW Viewpoint—Standardising acute myeloid leukaemia classification systems #leusm
https://t.co/OPLDAKvXXi
Welcome #AmgenScholars of 2022!
This summer, our Scholars will be conducting research, analyzing data, networking with other undergraduates and developing working relationships with faculty mentors and other research staff.
@AmgenFoundation@UofT
Most of us operate daily without much insight into what's going on in our cells.
So we often wait until symptoms show before knowing if something's wrong (e.g. heart disease, Alzheimer's, age-related disease).
At Biotein, we're building a <$30 device to change this.
I advise Biotein, a student-run startup focused on longevity and love what they're working on! They're doing market research interviews to figure out what people want in a product - if you are interested to help, go to https://t.co/qTriBSCkS1
We're now working with Ichor Therapeutics on building + validating our tech. So excited to be supported by this team of talented (and kind!) professionals!
We’re currently conducting 30-min interviews at @bioteinco to help guide our path as a company as we launch our saliva-based bio-age test to help you be informed about and take better care of your health.
If you're interested, you can sign up here: https://t.co/Z1T3OoDVJa!
"What is rare is not raw talent, skill, or even confidence, but humility, diligence, and self-awareness."
- Ego is the Enemy by Ryan Holiday
Only one chapter in and already learning big lessons.
@MadhavMalhotra_ Was listening to Philosophize This podcast episode on Emil, and was fascinated by his way of thinking, so I’ve just been looking into him a bit
Working at a startup is the wrong career choice for 90% of people.
I have worked at a:
• 20 person startup
• $100 billion company
Here's a framework for deciding between startups and big companies:
It's commonly believed that the immune system of the central nervous system is isolated from the peripheral immune system of the body, but Croese et al. review the increasing evidence disproving this notion and the impact this has on brain function, here:
https://t.co/1RafibzmIm